Oncology research and treatment
Krajnak S, Battista MJ, Hasenburg A, Schmidt M.
PMID: 34794154
Oncol Res Treat. 2021 Nov 18;1-6. doi: 10.1159/000520236. Epub 2021 Nov 18.
BACKGROUND: As disease control and quality of life play a leading role in metastatic breast cancer (MBC), metronomic chemotherapy (MCT) is gaining popularity alongside conventional chemotherapy (CCT) and targeted therapies.SUMMARY: MCT, defined as continuous administration of low-dose chemotherapeutic agents,...
Cite
Krajnak S, Battista MJ, Hasenburg A, et al. Metronomic Chemotherapy for Metastatic Breast Cancer. Oncol Res Treat. 2021;1-6doi: 10.1159/000520236.
Krajnak, S., Battista, M. J., Hasenburg, A., & Schmidt, M. (2021). Metronomic Chemotherapy for Metastatic Breast Cancer. Oncology research and treatment, 1-6. https://doi.org/10.1159/000520236
Krajnak, Slavomir, et al. "Metronomic Chemotherapy for Metastatic Breast Cancer." Oncology research and treatment vol. (2021): 1-6. doi: https://doi.org/10.1159/000520236
Krajnak S, Battista MJ, Hasenburg A, Schmidt M. Metronomic Chemotherapy for Metastatic Breast Cancer. Oncol Res Treat. 2021 Nov 18;1-6. doi: 10.1159/000520236. Epub 2021 Nov 18. PMID: 34794154.
Copy
Download .nbib
